Kuros Biosciences AG is a medical technology company focused on the development and commercialization of orthobiologics and advanced bone graft solutions. The company's flagship product, MagnetOs, is a synthetic biphasic calcium phosphate bone graft that utilizes a proprietary NeedleGrip surface technology to stimulate bone growth without the need for added cells or growth factors. MagnetOs is primarily used in spinal fusion procedures, with expanding applications in extremity and trauma surgeries. Kuros generates nearly all of its revenue from its Medical Devices segment, driven by direct sales in the United States and Europe, as well as through international distribution partnerships. Originally founded as a biotechnology firm, the company pivoted to orthobiologics following a 2016 reverse merger. Today, Kuros operates its global headquarters in Switzerland, with additional manufacturing and commercial operations in the Netherlands and the United States, positioning itself as a fast-growing player in the global orthopedic and spinal surgery markets.
